残肺癌外科手术治疗的临床评价与风险防范

Clinical evaluation and measures to keep away the risk on surgical treatment of residual lung cancer

目的:评价残肺癌手术切除的安全性及可行性,探讨防范风险的应对措施.方法:回顾性分析了1998～2003年我院胸外科收治的18例残肺癌患者资料.结果:18例患者中, Ⅱ期3例, ⅢA期12例, ⅢB期3例, 全组围手术期无死亡病例.术后随访3个月～5年,根治性手术后1、3和5年生存率分别为66.6%(11/16)、37.3%(5/13)和27.7%(2/7).结论:只要高度重视围手术期的处理,正确评估麻醉与手术的风险,把握手术时机及技巧,残肺癌的外科手术治疗仍是安全、有效、可行的.

OBJECTIVE:To evaluate the safety and feasibility of completing pneumonectomy for residual lung cancer, and explore the measures how to keep away its risk. METHODS: The clinical data of 18 cases admitted during the period from 1998 to 2003 were restrospectively analyzed. RESULTS: In this group, there were 3, 12, and 3 cases in pathological Stage Ⅱ, ⅢA and ⅢB, respectively. There was no case of operative death. The follow-up continued from 3 months to 5 years. The 1-, 3- and 5-year survival rates were 66.6%(11/16), 37.3%(5/13) and 27.7%(2/7),respectively. CONCLUSIONS: Only if pay more attention to perioperative managements, estimating the risk of the anaesthesia and operation correctly and commanding operative time and technical skill, the surgical treatment of residual lung cancer is safe, effective and feasible.